eye care business

News

Takeda could be considering selling Shire’s eye care business after their $62 billion merger next year to cut debts, according to press reports.

News

BioNTech's vaccine for head and neck cancer has failed a clinical trial, but it will wait for more data before deciding the programme's fate.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.